# CorePharma, LLC – FDA Inspection, Jan 20, 2010

Source: https://www.keypedia.com/records/fda_inspections/corepharma-llc/7e1b04c1-8d33-4fd2-9b0f-e1a3846a33e5
Source feed: FDA_Inspections

> FDA inspection 636223 of CorePharma, LLC, January 20, 2010. Classification: Official Action Indicated (OAI). 13 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 636223
- Company Name: CorePharma, LLC
- Inspection Date: 2010-01-20
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1280399 - 2025-08-28](https://www.keypedia.com/records/fda_inspections/corepharma-llc/a79456c1-10bd-4a42-b391-e30e7bd8084c)
- [FDA Inspection 1240419 - 2024-09-12](https://www.keypedia.com/records/fda_inspections/corepharma-llc/debe7cb9-f65c-449a-8bd8-1fa4d1291653)
- FDA Inspection 1087306 - 2019-03-29
- FDA Inspection 1029942 - 2017-10-13
- FDA Inspection 980585 - 2016-08-11

Company: https://www.keypedia.com/companies/corepharma-llc/037e485c-5d38-40e3-80fe-b00a72cda489

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c